Literature DB >> 29984642

Sitosterolemia: diagnosis, metabolic and hematological abnormalities, cardiovascular disease and management.

Jose Maria Bastida1, Maria Luisa Giros2, Rocio Benito3, Kamila Janusz3, Jesus Maria Hernandez-Rivas4, Jose Ramon Gonzalez-Porras1.   

Abstract

Sitosterolemia is a recessive inherited metabolic disorder of unknown prevalence, characterized by increased levels of plasma plant sterols. It is caused by 28 and 31 variants in ABCG5 and ABCG8 genes, respectively, and is characterized by a predisposition to hyperabsorption and accumulation of toxic levels of plant sterols in plasma. Its clinical picture is extremely heterogeneous. The main clinical features are tendinous and cutaneous xanthomas, arthritis or arthralgia, premature cardiovascular disease and atherosclerosis. These characteristics are shared with familial hypercholesterolemia (FH), making it possible for sitosterolemia to be misdiagnosed as homozygous FH, especially in pediatric patients. In such cases, a specific chromatography-based laboratory method is essential to differentiate sitosterol and cholesterol. Hematological abnormalities (hemolytic anemia and macrothrombocytopenia) may be present in 25-35% of patients, in whom it is usually associated with the main clinical features, as occurs in the 70% of the cases. In this context, the peripheral blood smear is essential and reveals giant platelets and stomatocytes. Only 21 causative variants in ABCG5/ABCG8 are associated with macrothrombocytopenia. Most physicians still do not recognize these hematological abnormalities or relate them to sitosterolemia. Patients may suffer long-term misdiagnosis of immune thrombocytopenia and be at high risk of receiving harmful therapies or of not benefitting from a low-cholesterol diet and/or from the gold standard treatment with ezetimibe. This drug reduces levels of plasma plant sterols, provokes regression of xanthomas, and can alleviate hematological abnormalities. Finally, to identify genetic defects, recent advances in high-throughput sequencing, especially in the use of targeted sequencing of pre-specified genes, have begun to be incorporated into the first-line approach in the field of genetic disorders. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  genetic testing. ; high-throughput nucleotide sequencing; lood platelet disorders; macrothrombocytopenia; sitosterol

Year:  2018        PMID: 29984642     DOI: 10.2174/0929867325666180705145900

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  7 in total

1.  Clinical characteristics of sitosterolemic children with xanthomas as the first manifestation.

Authors:  Jun Zhang; Qiu-Li Chen; Song Guo; Yan-Hong Li; Chuan Li; Ru-Jiang Zheng; Xue-Qun Luo; Hua-Mei Ma
Journal:  Lipids Health Dis       Date:  2022-10-13       Impact factor: 4.315

2.  Sitosterolemia: Four Cases of an Uncommon Cause of Hemolytic Anemia (Mediterranean Stomatocytosis with Macrothrombocytopenia).

Authors:  Sudhamsh Reddy Desai; Anu Korula; Uday Prakash Kulkarni; Aswathy Ashok Menon; Shaji V Ramachandran; Eunice Sindhuvi; Arun Jose Nellickal; Sukesh C Nair; Biju George
Journal:  Indian J Hematol Blood Transfus       Date:  2020-10-22       Impact factor: 0.900

Review 3.  Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor.

Authors:  Estíbaliz Jarauta; Ana Ma Bea-Sanz; Victoria Marco-Benedi; Itziar Lamiquiz-Moneo
Journal:  Front Genet       Date:  2020-12-03       Impact factor: 4.599

4.  Pediatric patients with familially inherited sitosterolemia: Two case reports.

Authors:  Shun-Qing Su; Di-Sheng Xiong; Xiu-Mei Ding; Jin-An Kuang; Yue-Chun Lin
Journal:  Front Cardiovasc Med       Date:  2022-08-16

5.  Sitosterolemia With Atherosclerosis in a Child: A Case Report.

Authors:  Hongjun Ba; Huimin Peng; Xiufang He; Liangping Cheng; Yuese Lin; Xuandi Li; Huishen Wang; Youzhen Qin
Journal:  Front Pediatr       Date:  2021-06-11       Impact factor: 3.418

Review 6.  Diagnosis and Management of Sitosterolemia 2021.

Authors:  Hayato Tada; Akihiro Nomura; Masatsune Ogura; Katsunori Ikewaki; Yasushi Ishigaki; Kyoko Inagaki; Kazuhisa Tsukamoto; Kazushige Dobashi; Kimitoshi Nakamura; Mika Hori; Kota Matsuki; Shizuya Yamashita; Shinji Yokoyama; Masa-Aki Kawashiri; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-04-28       Impact factor: 4.928

Review 7.  Features of chinese patients with sitosterolemia.

Authors:  Zhizi Zhou; Xueying Su; Yanna Cai; Tzer Hwu Ting; Wen Zhang; Yunting Lin; Aijing Xu; Xiaojian Mao; Chunhua Zeng; Li Liu; Xiuzhen Li
Journal:  Lipids Health Dis       Date:  2022-01-18       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.